CStone is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established at the end of 2015, CStone has assembled a world-class management team with extensive experience in innovative drug development, clinical research, and commercialization. With a strategic emphasis on immuno-oncology combination therapies, the Company has built an oncology-focused pipeline of 16 drug candidates, including 5 late-stage candidates at pivotal trials or registration stages. With an experienced team, a rich pipeline, a robust clinical development-driven business model and substantial funding, CStone’s vision is to become a world-renowned biopharmaceutical company that is leading the way to conquering cancer.

Pharmaceutical

CStone Pharmaceuticals

Jason Yang

Jason Li

Lian Liu

Qingmei Shi

Na Wen

Chao Arthur Wu

Juan Zhang

Anny-Yue Yin

Michael Choi

Josh Zhou

The Leadership Team at CStone Pharmaceuticals is responsible for steering the company's strategic vision and operational execution, focusing on the development and commercialization of innovative therapeutics for cancer treatment. Comprising key executives with expertise in drug development, clinical research, and market strategy, the team collaborates to ensure the successful advancement of CStone’s oncology pipeline, fostering partnerships and guiding crucial decisions that drive growth and enhance patient outcomes.

Leadership Team

Clinical and Medical Science Team

Marketing and Communications

Leadership Team

About

Team members

Other teams at CStone Pharmaceuticals

Clinical and Medical Science Team

Marketing and Communications